China Medical System (OTCMKTS:CHSYF) Trading Down 1.9%

China Medical System Holdings Limited (OTCMKTS:CHSYFGet Rating) fell 1.9% during mid-day trading on Monday . The company traded as low as $1.55 and last traded at $1.59. 2,648 shares were traded during trading, an increase of 6% from the average session volume of 2,487 shares. The stock had previously closed at $1.62.

The company’s 50 day simple moving average is $1.69 and its 200 day simple moving average is $1.79.

China Medical System Company Profile (OTCMKTS:CHSYF)

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. It offers products under the direct and agency networks. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.

Featured Articles

Receive News & Ratings for China Medical System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Medical System and related companies with's FREE daily email newsletter.